CVE-2022-26889

Exploitation

Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.

SSVC decision

Not assessed by CISA

EPSS probability

1.50% probability of exploitation activity in the next 30 days.

EPSS percentile

Equal to or higher than the score of 74.0% of scored records. A rank, not a probability.

NVD base score

8.8 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2022-05-06 16:37Z4 YR AGO

Last updated

2024-08-03 05:18Z2 YR AGO

Reserved

2022-03-21

Assigning CNA

Splunk

Record state

PUBLISHED

Severity

High (CVSS 8.8)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Weaknesses

• CWE-20Improper Input ValidationClass
• CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')Base

Data version

5.1

Document digest

dd3877913cc2a179953017d3c37c941ce844bceae88b6e3eb9e820d8662045e0

• www.splunk.comhttps://www.splunk.com/en_us/product-security/announcements/svd-2022-0506.htmlx_refsource_MISC
• research.splunk.comhttps://research.splunk.com/application/path_traversal_spl_injection/x_refsource_MISC